We are live on ! Find out more
HP

HealthInvest Partners Portfolio holdings

AUM $372M
1-Year Est. Return 59.89%
This Fund
S&P 500
This Quarter Est. Return
+0.93%
1 Year Est. Return
+59.89%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$47.4M
AUM Growth
-$38.3M
Cap. Flow
-$40.2M
Cap. Flow %
-84.84%
Top 10 Hldgs %
66.13%
Holding
16
New
4
Increased
–
Reduced
12
Closed
–

Top Buys

Rank Stock Value
1
CAH icon
Cardinal Health
CAH
+$2.82M
2
LLY icon
Eli Lilly
LLY
+$2.72M
3
BMY icon
Bristol-Myers Squibb
BMY
+$2.71M
4
DGX icon
Quest Diagnostics
DGX
+$2.7M

Top Sells

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$9.14M
2
MCK icon
McKesson
MCK
+$7.53M
3
CI icon
Cigna
CI
+$4.34M
4
WAT icon
Waters Corp
WAT
+$4.23M
5
BIIB icon
Biogen
BIIB
+$3.85M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANIK icon
1
Anika Therapeutics
ANIK
$216M
$6.18M 13.04%
114,600
-400
-0.3% -$22.1K
CRL icon
2
Charles River Laboratories
CRL
$11.3B
$2.92M 6.17%
26,712
-34,100
-56% -$3.71M
LH icon
3
Labcorp
LH
$25.2B
$2.84M 5.99%
20,719
-28,518
-58% -$3.77M
DGX icon
4
Quest Diagnostics
DGX
$26B
$2.81M 5.92%
+28,500
New +$2.7M
CAH icon
5
Cardinal Health
CAH
$53.7B
$2.79M 5.9%
+45,600
New +$2.82M
MCK icon
6
McKesson
MCK
$104B
$2.78M 5.86%
17,800
-50,800
-74% -$7.53M
ELV icon
7
Elevance Health
ELV
$81.5B
$2.77M 5.84%
12,300
-42,900
-78% -$9.14M
LGND icon
8
Ligand Pharmaceuticals
LGND
$5.77B
$2.77M 5.84%
32,381
-44,403
-58% -$3.85M
MDT icon
9
Medtronic
MDT
$112B
$2.76M 5.83%
34,200
-47,900
-58% -$3.84M
CI icon
10
Cigna
CI
$78.4B
$2.72M 5.74%
13,400
-21,800
-62% -$4.34M
PFE icon
11
Pfizer
PFE
$143B
$2.72M 5.74%
79,155
-111,935
-59% -$3.82M
WAT icon
12
Waters Corp
WAT
$37.3B
$2.71M 5.71%
14,000
-21,900
-61% -$4.23M
LLY icon
13
Eli Lilly
LLY
$1.08T
$2.7M 5.7%
+32,000
New +$2.72M
BIIB icon
14
Biogen
BIIB
$30.9B
$2.68M 5.65%
8,400
-12,000
-59% -$3.85M
BMY icon
15
Bristol-Myers Squibb
BMY
$129B
$2.66M 5.61%
+43,400
New +$2.71M
GILD icon
16
Gilead Sciences
GILD
$165B
$2.59M 5.46%
36,100
-40,500
-53% -$3.08M

Similar funds

KP
Kiltearn Partners Edinburgh, United Kingdom $372M AUM 18.16% 1-Year Est. Return
AWA
Acumen Wealth Advisors Chattanooga, Tennessee $372M AUM
TCM
Thomist Capital Management Houston, Texas $371M AUM 77.62% 1-Year Est. Return
SAAM
Solus Alternative Asset Management Summit, New Jersey $372M AUM 45.33% 1-Year Est. Return
SC
Saybrook Capital Winston Salem, North Carolina $371M AUM 13.23% 1-Year Est. Return
PAA
Peregrine Asset Advisers Portland, Oregon $371M AUM 41.36% 1-Year Est. Return
PC
Promethos Capital Boston, Massachusetts $372M AUM 23.19% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

HealthInvest Partners's Q4 2017 Portfolio in Review

As of Q4 2017, HealthInvest Partners held 16 positions worth $47.4M, down 45% from $85.6M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

HealthInvest Partners withdrew a net $40.2M in Q4 2017, reducing 12 holdings. Its largest reduction was Elevance Health, cutting an estimated $9.14M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, HealthInvest Partners opened a new position in Cardinal Health worth $2.79M.

  • HealthInvest Partners's largest Q4 2017 buy was Cardinal Health: 45,600 shares worth $2.79M.
  • HealthInvest Partners's biggest Q4 2017 reduction was Elevance Health, cutting an estimated $9.14M.
  • HealthInvest Partners's ten largest holdings make up 66% of its $47.4M portfolio in Q4 2017.
  • HealthInvest Partners opened 4 new positions and closed 0 in Q4 2017.
  • HealthInvest Partners's portfolio value fell 45% quarter-over-quarter to $47.4M.

Based on HealthInvest Partners's 13F filing for Q4 2017, filed 9 Feb 2018.